HPSE and Miyoshi myopathy: Heparanase (HPSE), an enzyme that cleaves the heparan sulfate chains of proteoglycans in the tumor microenvironment [3, 4], has been shown by us and others to promote tumor growth, angiogenesis and correlate with bone metastasis of a variety of cancer cells, including MM [5–10].